Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12377769 | 0.69 | — | — | |
| SCHEMBL12344272 | 0.64 | — | — | |
| SCHEMBL13006867 | 0.57 | KMT2A (0.42) | — | |
| SCHEMBL23641542 | 0.55 | L3MBTL1 (0.39) | L3MBTL1 | |
| SCHEMBL14882877 | 0.55 | L3MBTL1 (0.32) | L3MBTL1 | |
| SCHEMBL12191352 | 0.55 | NOTUM (0.39) | — | |
| SCHEMBL23196720 | 0.54 | IDO1 (0.33) | L3MBTL1 | |
| SCHEMBL21760765 | 0.54 | L3MBTL1 (0.41) | L3MBTL1 | |
| SCHEMBL23196710 | 0.54 | L3MBTL1 (0.35) | L3MBTL1 | |
| SCHEMBL21395095 | 0.52 | TLR9 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110098471-A1 | OXAZOLIDINONE DERIVATIVE HAVING FUSED RING | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098471-A1 | OXAZOLIDINONE DERIVATIVE HAVING FUSED RING | OXER1, ALOX12, CYP1A1 | L3MBTL1 2506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.